EUCTR2015-004896-60-NL进行中（未招募）不适用
Decitabine-cytarabine chemotherapy in elderly AML and high risk MDS patients (> 65 years) with high early mortality risk - Decitabine-cytarabine chemotherapy in elderly AML and high risk MDS patients
eiden University Medical Center0 个研究点开始时间: 2015年11月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with AML or high risk MDS (IPSS-R = 4.5)
- •> 65 years
- •WHO performance score 0-2
- •HCT-CI score >=2
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •Previous treatment with decitabine, azacitidine or intensive chemotherapy for this MDS/AML (treatment with chemotherapy for previous other diseases is acceptable)
- •Acute promyelocytic leukemia
研究者
相似试验
已完成
2 期
Decitabine-cytarabine chemotherapy in elderly AML and high risk MDS patients (> 65 years) with high early mortality riskmyelodysplasia10024324acute leukemiaNL-OMON42455eids Universitair Medisch Centrum19
尚未招募
不适用
Decitabine-cytarabine chemotherapy in elderly AML and high risk MDS patients (> 65 years) with high early mortality riskAcute myeloid leukemia (AML), Myelodysplasia (MDS), Acute myeloide leukemie, Myelodysplasie, Chemotherapy, ChemotherapieNL-OMON23606eiden University Medical Center (LUMC)20
已完成
不适用
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.Acute Myeloid LeukemiaNCT03350152Hospices Civils de Lyon302
进行中（未招募）
3 期
"InDACtion" vs "3+7" Induction in AMLAcute Myeloid Leukemia (AML)NCT02172872European Organisation for Research and Treatment of Cancer - EORTC606
Unknown
1 期
Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)Acute Myeloid LeukemiaNCT01488344University Hospital Muenster140